Skip to content

Drug interactions

Certolizumab pegol + Rituximab

Severity: Major

Certolizumab pegol and Rituximab: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

B-cell depletion combined with TNF inhibition increases the risk of serious infection. Hypogammaglobulinemia from rituximab may further add to the risk.

What this interaction means in plain words

Certolizumab pegol and Rituximab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Certolizumab pegol belongs to Musculoskeletal; Rituximab belongs to Musculoskeletal.

Evidence level: Moderate

Why it happens

Additive immunosuppression from TNF-alpha blockade and CD20-mediated B-cell depletion.

What to do

Avoid overlapping use where possible. If sequential use is needed, monitor for infection and check immunoglobulin levels.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Certolizumab pegol and Rituximab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Certolizumab pegol with Rituximab?

MediHelp rates the interaction as major. Certolizumab pegol and Rituximab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. B-cell depletion combined with TNF inhibition increases the risk of serious infection. Hypogammaglobulinemia from rituximab may further add to the risk.

How serious is the interaction between Certolizumab pegol and Rituximab?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid overlapping use where possible. If sequential use is needed, monitor for infection and check immunoglobulin levels.

What other medicines interact with Certolizumab pegol?

MediHelp also lists interactions of Certolizumab pegol with, for example, Adenovirus types 4 and 7 live, Bcg intravesical live, Bcg vaccine live. The full list is on the Certolizumab pegol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in